Govt begins work on 3 more compulsory licences

DIPP wants foolproof case on anti-cancer drugs of Roche, Bristol-Myers

The department of industrial policy and promotion is actively considering the grant of compulsory licences for three new anti-cancer drugs. The department, a wing of the commerce ministry, which also looks at intellectual property-related issues, has sought details regarding prices, efficacy levels and size of the patient pool in need of such treatment from the health ministry, a government official said. The proposal, initially mooted by a panel formed under the health ministry, recommends invoking the compulsory licence rule for three drugs— trastuzumab, ixabepilone ...